# Filing Detail

Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001144204-17-005958
Filing Date
2017-02-03
Accepted
2017-02-03 17:14:39
Documents
7
Period of Report
2017-02-03

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PREM14A | v457435_prem14a.htm | PREM14A | 2424456
2 | GRAPHIC | image_001.jpg | GRAPHIC | 3947
3 | GRAPHIC | image_002.jpg | GRAPHIC | 3778
4 | GRAPHIC | pg2img1_prem14a.jpg | GRAPHIC | 15052
5 | GRAPHIC | pg5img1_prem14a.jpg | GRAPHIC | 15254
6 | GRAPHIC | proxy1_prem14a.jpg | GRAPHIC | 280184
7 | GRAPHIC | proxy2_prem14a.jpg | GRAPHIC | 194430
| Complete submission text file | 0001144204-17-005958.txt |  | 3132316

Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36439 | Film No.: 17573046
SIC: 3826 Laboratory Analytical Instruments